What's in Tatchempharmpreparaty, JSC's pipeline?

Tatchempharmpreparaty, JSC has 1 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Tatchempharmpreparaty, JSC's portfolio?

Top competitors by shared drug class: AUVA Traumazentrum Vienna Site UKH Meidling, Aarhus University Hospital, Amgen, Axsome Therapeutics, Inc., Chinese Society of Lung Cancer.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/tatchempharmpreparaty-jsc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Tatchempharmpreparaty, JSC — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Tatchempharmpreparaty, JSC pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Dimephosphon®	Dimephosphon®	phase 3	Bisphosphonate	Farnesyl pyrophosphate synthase (indirect); osteoclast function	Bone metabolism / Rheumatology

Therapeutic area mix

Bone metabolism / Rheumatology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

AUVA Traumazentrum Vienna Site UKH Meidling · 1 shared drug class
Aarhus University Hospital · 1 shared drug class
Amgen · 1 shared drug class
Axsome Therapeutics, Inc. · 1 shared drug class
Chinese Society of Lung Cancer · 1 shared drug class
Chinese University of Hong Kong · 1 shared drug class
Cttq · 1 shared drug class
· 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Tatchempharmpreparaty, JSC:

Cite this brief

Drug Landscape (2026). Tatchempharmpreparaty, JSC — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/tatchempharmpreparaty-jsc. Accessed 2026-05-17.